AGL 40.00 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 129.53 Decreased By ▼ -2.20 (-1.67%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.63 Increased By ▲ 0.16 (3.58%)
DCL 8.94 Increased By ▲ 0.12 (1.36%)
DFML 41.69 Increased By ▲ 1.08 (2.66%)
DGKC 83.77 Decreased By ▼ -0.31 (-0.37%)
FCCL 32.77 Increased By ▲ 0.43 (1.33%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.47 Increased By ▲ 0.12 (1.06%)
HUBC 110.55 Decreased By ▼ -1.21 (-1.08%)
HUMNL 14.56 Increased By ▲ 0.25 (1.75%)
KEL 5.39 Increased By ▲ 0.17 (3.26%)
KOSM 8.40 Decreased By ▼ -0.58 (-6.46%)
MLCF 39.79 Increased By ▲ 0.36 (0.91%)
NBP 60.29 No Change ▼ 0.00 (0%)
OGDC 199.66 Increased By ▲ 4.72 (2.42%)
PAEL 26.65 Decreased By ▼ -0.04 (-0.15%)
PIBTL 7.66 Increased By ▲ 0.18 (2.41%)
PPL 157.92 Increased By ▲ 2.15 (1.38%)
PRL 26.73 Increased By ▲ 0.05 (0.19%)
PTC 18.46 Increased By ▲ 0.16 (0.87%)
SEARL 82.44 Decreased By ▼ -0.58 (-0.7%)
TELE 8.31 Increased By ▲ 0.08 (0.97%)
TOMCL 34.51 Decreased By ▼ -0.04 (-0.12%)
TPLP 9.06 Increased By ▲ 0.25 (2.84%)
TREET 17.47 Increased By ▲ 0.77 (4.61%)
TRG 61.32 Decreased By ▼ -1.13 (-1.81%)
UNITY 27.43 Decreased By ▼ -0.01 (-0.04%)
WTL 1.38 Increased By ▲ 0.10 (7.81%)
BR100 10,407 Increased By 220 (2.16%)
BR30 31,713 Increased By 377.1 (1.2%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)

NEW YORK: The Nasdaq and the S&P 500 rose in choppy, range-bound trading on Monday as investors looked forward to a raft of upcoming triggers such as Big Tech earnings, a Federal Reserve policy decision on interest-rate cuts and key labor data.

Nvidia, Apple, Alphabet, Amazon.com, Microsoft and Meta Platforms were flat to 1.2% up, but off the day’s highs.

Tesla was the top megacaps gainer, up 5% after Morgan Stanley added the EV maker’s stock to its “top pick” US autos’ list.

Coupled with a 4% rise in McDonald’s after a sales beat on its $5-meal deal, launched late in June, Tesla’s gains helped the S&P 500 Consumer Discretionary index rise 0.9%, topping sectoral gainers.

At 11:59 a.m. ET, the Dow Jones Industrial Average was down 2.65 points, or 0.01%, at 40,586.69, the S&P 500 was up 13.41 points, or 0.25%, at 5,472.51, and the Nasdaq Composite was up 58.40 points, or 0.34%, at 17,416.28.

In a major test for markets, investors will parse earnings from Microsoft, Meta, Apple and Amazon.com starting on Tuesday, to gauge if the AI-led equity rally has room to grow.

Technology behemoths have dominated Wall Street’s record-breaking run, prompting investors to start turning their attention to laggards such as mid and small caps, which are expected to benefit from a low-interest-rate environment.

However, the small-cap Russell 2000 dropped 0.8% after three straight weeks of gains.

The three major US stock indexes jumped more than 1% on Friday after hopes of an early monetary policy easing were boosted by an encouraging US inflation report, close on the heels of recent data signaling a loosening jobs market.

However, the S&P 500 and the Nasdaq closed the week lower after a disappointing start to tech earnings prompted the indexes to log their steepest one-day slide since 2022 on Wednesday.

Hopes are now pinned on the Fed signaling a rate cut in September in Wednesday’s policy verdict, with odds of a 25-basis-point reduction standing at 90%, according to the CME’s FedWatch. Any hawkish commentary at this stage could put equities under renewed selling pressure.

“The continued phraseology will be getting close to where we want to be, but just not there yet,” said Phil Blancato, CEO of Ladenburg Thalmann Asset Management.

“You’d expect the Fed to continue to pause for now and then potentially set (rate-cut expectations) up for September, although in my opinion (it) is still December.” A slew of employment reports this week, including the Non-farm Payrolls, will be scrutinized for insight into a somewhat easing labor market.

Crypto stocks Coinbase Global, Riot Platforms and Marathon Digital also fell around 2% each, after jumping in early trading as bitcoin prices touched a seven-week high.

Abbott Laboratories dropped 1.3% after a jury ordered it to pay $495 million in damages in a trial that found the healthcare company’s formula for premature infants had caused a dangerous illness.

Comments

Comments are closed.